AN ETHIC SYSTEM OVERVIEW- BRAZILIAN PERSPECTIVES FOR OBSERVATIONAL STUDIES

Author(s)

Minowa E1, Bueno CC1, Piedade A1, Clark LG1, Santinho CS1, de Castro Monteiro DC2, Feijo LF1, Ueda K3, Matos GM4, Hashimoto DA4
1Evidências Credibilidade Científica, São Paulo, Brazil, 2Roche Product New Zealand, Auckland, New Zealand, 3Harvard Medical School, Tokyo, Japan, 4Universidade de São Paulo, São Paulo, Brazil

AN ETHIC SYSTEM OVERVIEW: BRAZILIAN PERSPECTIVES FOR OBSERVATIONAL STUDIES  Background             Observational studies have been one of the hallmarks for the development of public health and health economics fields. It includes epidemiologic studies, evaluation of patterns of care, use of resources, cost of illness, analysis of safety and effectiveness of interventions from real world. However, there are different patterns of requirements for ethics reviews concerning observational studies, including vastly available models of ethics systems among different countries.  Therefore, the objective of this study is to evaluate the ethics system, regulations and guidelines concerning observational studies in the selected countries. Methodology             Guidelines and regulations from Brazil, Argentina, Japan, New Zealand, Australia, USA and UK were reviewed to evaluate the ethics system and available guiding principle for observational studies. Additionally, a literature review was performed in the database Medline and SciELO mesh using the terms "ethics", “observational study” and "multicenter study" among other similar terms. Results             In Brazil, same ethics regulation is applied for both interventional and observational projects, plus there is unsatisfactory ethics review timelines and duplicity of ethics review when considering multicenter studies. Specific pathways for multicenter studies are available only in New Zealand, Australia, USA and UK. For the exception of Brazil, other evaluated countries have specific guidelines, recommendations or regulations for observational studies. Conclusions             Brazil and Argentina still have a lot of challenges to overcome regarding the overall ethics system. Applying same ethics regulations or guidelines from interventional studies may not be the most adequate choice for observational studies.

Conference/Value in Health Info

2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands

Value in Health, Vol. 17, No. 7 (November 2014)

Code

PHP285

Topic

Health Policy & Regulatory

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×